Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593893 | SCV000709264 | likely pathogenic | not provided | 2017-06-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000056074 | SCV001229624 | pathogenic | Cholestanol storage disease | 2024-01-12 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 395 of the CYP27A1 protein (p.Arg395His). RNA analysis indicates that this missense change induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs587778778, gnomAD 0.04%). This missense change has been observed in individual(s) with cerebrotendinous xanthomatosis (PMID: 8950197). This variant is also known as Arg362His. ClinVar contains an entry for this variant (Variation ID: 65834). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects CYP27A1 function (PMID: 17697869). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this missense change results in skipping of exon 6 and activation of a cryptic splice site and introduces a premature termination codon (PMID: 9548584). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV000593893 | SCV001248937 | pathogenic | not provided | 2018-01-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000056074 | SCV002018122 | pathogenic | Cholestanol storage disease | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000056074 | SCV002060391 | likely pathogenic | Cholestanol storage disease | 2021-11-03 | criteria provided, single submitter | clinical testing | NM_000784.3(CYP27A1):c.1184G>A(R395H) is a missense variant classified as likely pathogenic in the context of cerebrotendinous xanthomatosis. R395H has been observed in cases with relevant disease (PMID: 11181744, 8950197). Functional assessments of this variant are available in the literature (PMID 7697869, 8950197, 9548584). R395H has been observed in population frequency databases (gnomAD: ASJ 0.06%). In summary, NM_000784.3(CYP27A1):c.1184G>A(R395H) is a missense variant that has functional support for pathogenicity and has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. |
Gene |
RCV000593893 | SCV003933228 | likely pathogenic | not provided | 2023-06-14 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect, as the variant leads to aberrant splicing and a non-functional enzyme (Chen et al., 1998); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32344004, 34689324, 16816916, 33704661, 17697869, 11181744, 8950197, 9521761, 27175728, 26643207, 9548584) |
Baylor Genetics | RCV000056074 | SCV004192667 | likely pathogenic | Cholestanol storage disease | 2024-03-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000056074 | SCV000087139 | pathologic | Cholestanol storage disease | 2013-08-01 | no assertion criteria provided | curation | Converted during submission to Pathogenic. |
Natera, |
RCV000056074 | SCV002078802 | pathogenic | Cholestanol storage disease | 2020-01-20 | no assertion criteria provided | clinical testing | |
Kasturba Medical College, |
RCV000056074 | SCV002573718 | likely pathogenic | Cholestanol storage disease | no assertion criteria provided | clinical testing |